KalVista Pharmaceuticals, Inc.
KalVista Pharmaceuticals, Inc. (KALV) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · KALV · as of Jun 8, 2026
Key Statistics
Explore KalVista Pharmaceuticals, Inc. Data
kalv stock data · financialsCompetitors & Peers
kalv competitorsKALV
ADCT
BCYC
FDMT
GOSS
OLMAAbout KalVista Pharmaceuticals, Inc.
KalVista Pharmaceuticals, Inc. a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product…
what is kalvista pharmaceuticals, inc. · kalv stock overview · kalvista pharmaceuticals, inc. company profile · who is kalvista pharmaceuticals, inc. ceo · kalv NASDAQ · kalvista pharmaceuticals, inc. headquarters · kalvista pharmaceuticals, inc. business segments
About Stock Overview & Key Data
KalVista Pharmaceuticals, Inc. (KALV) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 9, 2015. As of the latest trading session, KALV stock price is $26.95, with a market capitalization of $1.4B. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, KalVista Pharmaceuticals, Inc. (KALV) stock price is $26.95. The stock is traded on NASDAQ under the ticker symbol KALV. The 52-week range is $9.83 – $26.98.